Case Details

CourtDistrict of Massachusetts
Docket number1:10-cv-12079
Date case filed2010-12-02
Date case closed2016-03-03
Date of latest filing
Assigned toJudge Nathaniel M. Gorton
Case cause35:271 Patent Infringement
Nature of suit830 Patent
Jury demandPlaintiff
Demand
JurisdictionFederal Question

Case Parties

Party: Momenta Pharmaceuticals, Inc.
Party type: Plaintiff
Attorney name: Robert S. Frank , Jr.
Attorney Contact:
Choate, Hall & Stewart
Two International Place
100-150 Oliver Street
Boston, MA 02110
617-248-5207
Fax: 617-248-4000
Email: [email protected]
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Anna Rachel Dray-Siegel
Attorney Contact:
Attorney General's Office
Administrative Law Division
One Ashburton Place
Boston, MA 02108
617-963-2022
Email: [email protected]
ATTORNEY TO BE NOTICED

Attorney name: Daniel C. Winston
Attorney Contact:
Choate, Hall & Stewart
Two International Place
100-150 Oliver Street
Boston, MA 02110
617-248-5000
Fax: 617-248-4000
Email: [email protected]
ATTORNEY TO BE NOTICED

Attorney name: Eric J. Marandett
Attorney Contact:
Choate, Hall & Stewart
Two International Place
100-150 Oliver Street
Boston, MA 02110
617-248-5000
Fax: 617-248-4000
Email: [email protected]
ATTORNEY TO BE NOTICED

Attorney name: G. Mark Edgarton
Attorney Contact:
Choate, Hall & Stewart LLP
Two International Place
100-150 Oliver Street
Boston, MA 02110
617-248-5101
Fax: 617-248-4000
Email: [email protected]
ATTORNEY TO BE NOTICED

Attorney name: Jessica Gan Lee
Attorney Contact:
Choate, Hall & Stewart LLP
Two International Place
100-150 Oliver Street
Boston, MA 02110
617-248-5000
Fax: 617-248-4000
Email: [email protected]
TERMINATED: 09/05/2013 ATTORNEY TO BE NOTICED

Attorney name: Kara B. Coen
Attorney Contact:
Gibson, Dunn & Crutcher
1050 Connecticut Avenue, N.W.
Washington, DC 20036-5303
202-955-8500
Fax: 202-467-0539
Email: [email protected]
TERMINATED: 01/28/2013 ATTORNEY TO BE NOTICED

Attorney name: Michael E. Murawski
Attorney Contact:
Choate, Hall & Stewart LLP
Two International Place
100-150 Oliver Street
Boston, MA 02110
617-248-4996
Fax: 617-502-4996
Email: [email protected]
TERMINATED: 07/01/2014 ATTORNEY TO BE NOTICED

Attorney name: Sophie F. Wang
Attorney Contact:
Choate, Hall & Stewart
Two International Place
100-150 Oliver Street
Boston, MA 02110
617-248-4052
Email: [email protected]
ATTORNEY TO BE NOTICED
Party: Sandoz Inc.
Party type: Plaintiff
Attorney name: Sarah Chapin Columbia
Attorney Contact:
McDermott, Will & Emery LLP
28 State Street
Boston, MA 02109
617-535-4074
Fax: 617-535-3800
Email: [email protected]
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: G. Mark Edgarton
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED

Attorney name: Jessica Gan Lee
Attorney Contact:
(See above for address)
TERMINATED: 09/05/2013

Attorney name: Melissa Nott Davis
Attorney Contact:
McDermott, Will & Emery LLP
28 State Street
Boston, MA 02109
617-535-4189
Fax: 617-535-3800
Email: [email protected]
ATTORNEY TO BE NOTICED

Attorney name: Michael E. Murawski
Attorney Contact:
(See above for address)
TERMINATED: 07/01/2014 ATTORNEY TO BE NOTICED

Attorney name: Thomas P. Steindler
Attorney Contact:
McDermott Will & Emery LLP
500 North Capitol Street, N.W.
Washington, DC 20001
202-756-8254
Email: [email protected]
PRO HAC VICE ATTORNEY TO BE NOTICED
Party: Teva Pharmaceutical Industries, Ltd.
Party type: Defendant
Attorney name: Adam R. Wichman
Attorney Contact:
Goodwin Procter, LLP
One Exchange Place
53 State Street
Boston, MA 02109
617-570-3973
Email: [email protected]
TERMINATED: 09/11/2012 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: David M. Hashmall
Attorney Contact:
Goodwin Procter LLP
The New York Times Buildings
620 Eighth Avenue
New York, NY 10018
212-813-8800
Fax: 212-355-3333
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Elaine Herrmann Blais
Attorney Contact:
Goodwin Procter LLP
Exchange Place
53 State Street
Boston, MA 02109
617-570-1205
Fax: 617-523-1231
Email: [email protected]
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: James Rehnquist
Attorney Contact:
Goodwin Procter, LLP
Exchange Place
53 State Street
Boston, MA 02109
617-570-1820
Fax: 617-523-1231
Email: [email protected]
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Robert Frederickson , III
Attorney Contact:
Goodwin Procter LLP
Exchange Place
53 State Street
Boston, MA 02109
617-570-1000
Fax: 617-523-1231
Email: [email protected]
LEAD ATTORNEY ATTORNEY TO BE NOTICED
Party: Teva Pharmaceuticals USA Inc
Party type: Defendant
Attorney name: Adam R. Wichman
Attorney Contact:
(See above for address)
TERMINATED: 09/11/2012 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Daniel B. Reagan
Attorney Contact:
Goodwin Procter, LLP
One Exchange Place
53 State Street
Boston, MA 02109
617-570-1000
Email: [email protected]
TERMINATED: 12/02/2013 LEAD ATTORNEY PRO HAC VICE ATTORNEY TO BE NOTICED

Attorney name: David M. Hashmall
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Elaine Herrmann Blais
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: James Rehnquist
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Joshua A. Whitehill
Attorney Contact:
Goodwin Procter LLP
The New York Times Building
620 Eighth Avenue
New York, NY 10018
212-459-7289
Fax: 212-355-3333
Email: [email protected]
LEAD ATTORNEY PRO HAC VICE ATTORNEY TO BE NOTICED

Attorney name: Robert Frederickson , III
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: G. Mark Edgarton
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED
Party: Judith G. Dein
Party type: Mediator
TERMINATED: 06/08/2012
Party: Amphastar Pharmaceuticals, Inc.
Party type: Intervenor
TERMINATED: 05/17/2013
Attorney name: Taylor C. Foss
Attorney Contact:
K & L Gates LLP
1 Park Plaza
12th Floor
Irvine, CA
949-623-3522
Email: [email protected]
LEAD ATTORNEY ATTORNEY TO BE NOTICED
Party: Teva Pharmaceuticals USA, Inc.
Party type: Counter Claimant
Attorney name: Adam R. Wichman
Attorney Contact:
(See above for address)
TERMINATED: 09/11/2012 LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Daniel B. Reagan
Attorney Contact:
(See above for address)
TERMINATED: 12/02/2013 LEAD ATTORNEY PRO HAC VICE ATTORNEY TO BE NOTICED

Attorney name: David M. Hashmall
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Elaine Herrmann Blais
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: James Rehnquist
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Robert Frederickson , III
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED
Party: Momenta Pharmaceuticals, Inc.
Party type: Counter Defendant
Attorney name: Robert S. Frank , Jr.
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Daniel C. Winston
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED

Attorney name: Eric J. Marandett
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED

Attorney name: G. Mark Edgarton
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED

Attorney name: Michael E. Murawski
Attorney Contact:
(See above for address)
TERMINATED: 07/01/2014 ATTORNEY TO BE NOTICED
Party: Sandoz Inc.
Party type: Counter Defendant
Attorney name: Sarah Chapin Columbia
Attorney Contact:
(See above for address)
LEAD ATTORNEY ATTORNEY TO BE NOTICED

Attorney name: Melissa Nott Davis
Attorney Contact:
(See above for address)
ATTORNEY TO BE NOTICED

Attorney name: Michael E. Murawski
Attorney Contact:
(See above for address)
TERMINATED: 07/01/2014 ATTORNEY TO BE NOTICED

Attorney name: Thomas P. Steindler
Attorney Contact:
(See above for address)
PRO HAC VICE ATTORNEY TO BE NOTICED

Case Docket

Docket
Item
Date FiledDocument
Available
Short
Description
Long Description
12010-12-02 COMPLAINT against All Defendants Filing fee: $ 350, receipt number 0101-3173882 (Fee Status: Filing Fee paid), filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A1 '886 Patent, # 2 Exhibit A2 '886 Patent, # 3 Exhibit A3 '886 Patent, # 4 Exhibit A4 '886 Patent, # 5 Exhibit A5 '886 Patent, # 6 Exhibit B1 '466 Patent, # 7 Exhibit B2 '466 Patent, # 8 Exhibit B3 '466 Patent, # 9 Exhibit C Teva's Q4 Earnings Conference Transcript, # 10 Exhibit D Teva's Q1 2010 Earnings Call, # 11 Exhibit E Teva's Press Release, # 12 Exhibit F Teva's Q2 2010 Earnings Conference Transcript, # 13 Exhibit G Teva Article, # 14 Exhibit H Teva's Q3 2010 Earnings Conference Transcript, # 15 Civil Cover Sheet, # 16 Category Form)(Murawski, Michael) (Entered: 12/02/2010)
1.1 Exhibit A1 '886 Patent
1.2 Exhibit A2 '886 Patent
1.3 Exhibit A3 '886 Patent
1.4 Exhibit A4 '886 Patent
1.5 Exhibit A5 '886 Patent
1.6 Exhibit B1 '466 Patent
1.7 Exhibit B2 '466 Patent
1.8 Exhibit B3 '466 Patent
1.9 Exhibit C Teva's Q4 Earnings Conference Transcript
1.10 Exhibit D Teva's Q1 2010 Earnings Call
1.11 Exhibit E Teva's Press Release
1.12 Exhibit F Teva's Q2 2010 Earnings Conference Transcript
1.13 Exhibit G Teva Article
1.14 Exhibit H Teva's Q3 2010 Earnings Conference Transcript
1.15 Civil Cover Sheet
1.16 Category Form
22010-12-02 CORPORATE DISCLOSURE STATEMENT by Momenta Pharmaceuticals, Inc.. (Murawski, Michael) (Entered: 12/02/2010)
32010-12-02 CORPORATE DISCLOSURE STATEMENT by Sandoz Inc.. (Murawski, Michael) (Entered: 12/02/2010)
42010-12-02 REPORT on the filing/termination of patent/trademark case Action Regarding Patent. (Murawski, Michael) (Entered: 12/02/2010)
52010-12-02 NOTICE of Appearance by Robert S. Frank, Jr on behalf of Momenta Pharmaceuticals, Inc. (Frank, Robert) (Entered: 12/02/2010)
62010-12-02 NOTICE of Appearance by Eric J. Marandett on behalf of Momenta Pharmaceuticals, Inc. (Marandett, Eric) (Entered: 12/02/2010)
72010-12-03 ELECTRONIC NOTICE of Case Assignment. Magistrate Judge Robert B. Collings assigned to case. Plaintiff's counsel, or defendant's counsel if this case was initiated by the filing of a Notice of Removal, are directed to the attached General Order and Notice regarding Consent to Proceed before the Magistrate Judge. These documents will be mailed to counsel not receiving notice electronically. (Attachments: # 1 Consent Form)(Cummings, Mary) (Entered: 12/03/2010)
82010-12-03 Summons Issued as to Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. Counsel receiving this notice electronically should download this summons, complete one for each defendant and serve it in accordance with Fed.R.Civ.P. 4 and LR 4.1. Summons will be mailed to plaintiff(s) not receiving notice electronically for completion of service. (Cummings, Mary) (Entered: 12/03/2010)
92010-12-08 SUMMONS Returned Executed Teva Pharmaceuticals USA, Inc. served on 12/6/2010, answer due 12/27/2010. (Murawski, Michael) (Entered: 12/08/2010)
102010-12-09 NOTICE of Appearance by Melissa Nott Davis on behalf of Sandoz Inc. (Davis, Melissa) (Entered: 12/09/2010)
112010-12-09 NOTICE of Appearance by Sarah Chapin Columbia on behalf of Sandoz Inc. (Columbia, Sarah) (Entered: 12/09/2010)
122010-12-14 Refusal to Consent to Proceed Before a US Magistrate Judge.. (Murawski, Michael) (Entered: 12/14/2010)
132010-12-16 NOTICE of Reassignment. Judge Nathaniel M. Gorton added. Magistrate Judge Robert B. Collings no longer assigned to case. (Duong, Diep) (Entered: 12/16/2010)
142010-12-17 NOTICE of Appearance by Elaine Herrmann Blais on behalf of Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc. (Blais, Elaine) (Entered: 12/17/2010)
152010-12-17 Assented to MOTION for Leave to Appear Pro Hac Vice for admission of David M. Hashmall Filing fee: $ 50, receipt number 0101-3196660 by Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit Certification fo David M. Hashmall)(Blais, Elaine) (Entered: 12/17/2010)
162010-12-17 NOTICE of Appearance by Adam R. Wichman on behalf of Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc. (Wichman, Adam) (Entered: 12/17/2010)
172010-12-17 CORPORATE DISCLOSURE STATEMENT by Teva Pharmaceuticals USA, Inc. identifying Corporate Parent Teva Pharmaceuticals Industries Ltd. for Teva Pharmaceuticals USA, Inc... (Blais, Elaine) (Entered: 12/17/2010)
182010-12-17 NOTICE of Appearance by Robert Frederickson, III on behalf of Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc. (Frederickson, Robert) (Entered: 12/17/2010)
192010-12-23 STIPULATION and Order Waiving Service of Process as to Defendant Teva Pharmaceutical Industries Ltd. and Extending Time to Answer, Move or Otherwise Respond to Plaintiffs' Complaint by Momenta Pharmaceuticals, Inc., Sandoz Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) (Entered: 12/23/2010)
202010-12-28 MOTION for Discovery [Motion for Limited Expedited Discovery] by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A)(Murawski, Michael) (Entered: 12/28/2010)
212010-12-28 MEMORANDUM in Support re 20 MOTION for Discovery [Motion for Limited Expedited Discovery] filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Murawski, Michael) (Entered: 12/28/2010)
222010-12-28 DECLARATION re 20 MOTION for Discovery [Motion for Limited Expedited Discovery] by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H)(Murawski, Michael) (Entered: 12/28/2010)
232010-12-29 CERTIFICATE OF CONSULTATION pursuant to LR 7.1 re 20 MOTION for Discovery [Motion for Limited Expedited Discovery] by Michael E. Murawski on behalf of All Plaintiffs. (Murawski, Michael) (Entered: 12/29/2010)
242011-01-03 NOTICE of Appearance by James Rehnquist on behalf of Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc. (Rehnquist, James) (Entered: 01/03/2011)
252011-01-05 MOTION for Extension of Time to January 13, 2011 to File Opposition to Plaintiff's Motion for Limited Expedited Discovery (Unopposed) by Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Blais, Elaine) (Entered: 01/05/2011)
262011-01-06 MOTION for Leave to Appear Pro Hac Vice for admission of Thomas P. Steindler Filing fee: $ 50, receipt number 0101-3218896 by Sandoz Inc.. (Attachments: # 1 Affidavit Affidavit of Thomas P. Steindler)(Columbia, Sarah) (Entered: 01/06/2011)
272011-01-13 STIPULATION of Dismissal of Complaint as to Defendant Teva Pharmaceutical Industries, Ltd. and Amendment of Caption by Momenta Pharmaceuticals, Inc., Sandoz Inc., Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) (Entered: 01/13/2011)
282011-01-13 Opposition re 20 MOTION for Discovery [Motion for Limited Expedited Discovery] (Defendants' Opposition to Plaintiffs' Motion for Expedited Discovery) filed by Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Rehnquist, James) (Entered: 01/13/2011)
292011-01-13 DECLARATION re 28 Opposition to Motion, (Declaration of Elaine Herrmann Blais in Support of Defendants' Opposition to Plaintiffs' Motion for Expedited Discovery) by Teva Pharmaceuticals Industries Ltd., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A)(Blais, Elaine) (Entered: 01/13/2011)
302011-01-19 ANSWER to 1 Complaint,,,, COUNTERCLAIM against Momenta Pharmaceuticals, Inc., Sandoz Inc. by Teva Pharmaceuticals USA, Inc..(Rehnquist, James) (Entered: 01/19/2011)
312011-02-01 MOTION for Leave to File a Reply Memorandum in Support of Plaintiffs' Motion for Limited Expedited Discovery by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A - Proposed Reply Memorandum in Support of Plaintiffs Momenta Pharmaceuticals, Inc. and Sandoz Inc.'s Motion for Limited Expedited Discovery)(Murawski, Michael) (Entered: 02/01/2011)
322011-02-08 Assented to MOTION for Leave to File a Sur-Reply in Opposition to Plaintiffs' Motion for Limited Expedited Discovery by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A)(Rehnquist, James) (Entered: 02/08/2011)
332011-02-08 NOTICE by Teva Pharmaceuticals USA, Inc. re 31 MOTION for Leave to File a Reply Memorandum in Support of Plaintiffs' Motion for Limited Expedited Discovery (Blais, Elaine) (Entered: 02/08/2011)
342011-02-09 Plaintiffs' ANSWER to Counterclaim of Defendant by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Murawski, Michael) (Entered: 02/09/2011)
352011-02-14 NOTICE of Scheduling Conference Scheduling Conference set for 3/11/2011 02:00 PM in Courtroom 4 before Judge Nathaniel M. Gorton. (Nicewicz, Craig) (Entered: 02/14/2011)
362011-02-18 NOTICE of Appearance by Emily L. Rapalino on behalf of Teva Pharmaceuticals USA, Inc. (Rapalino, Emily) (Entered: 02/18/2011)
372011-02-18 Judge Nathaniel M. Gorton: ORDER entered "In accordance with the foregoing, plaintiffs' motion forexpedited discovery (Docket No. 20 ) is DENIED." (Duong, Diep) (Entered: 02/22/2011)
382011-03-04 Joint MOTION for Protective Order [For Entry of Stipulated Protective Order] by Momenta Pharmaceuticals, Inc., Sandoz Inc., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A)(Murawski, Michael) (Entered: 03/04/2011)
392011-03-04 JOINT SUBMISSION pursuant to Local Rule 16.1 [Joint Statement Pursuant to L.R. 16.1(D) and 16.6 and [Proposed] Discovery Plan by Momenta Pharmaceuticals, Inc., Sandoz Inc., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A)(Murawski, Michael) (Entered: 03/04/2011)
402011-03-08 CERTIFICATION pursuant to Local Rule 16.1 of Defendant Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) (Entered: 03/08/2011)
412011-03-15 SUR-REPLY to Motion re 20 MOTION for Discovery [Motion for Limited Expedited Discovery] filed by Teva Pharmaceuticals USA, Inc.. (Rehnquist, James) (Entered: 03/15/2011)
422011-03-15 DECLARATION re 41 Sur-Reply to Motion IN FURTHER OPPOSITION TO PLAINTIFF'S MOTION FOR EXPEDITED DISCOVERY by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A)(Rehnquist, James) (Entered: 03/15/2011)
432011-03-15 Judge Nathaniel M. Gorton: ORDER entered. REFERRING CASE to Alternative Dispute Resolution for Mediation, February, 2012.(Patch, Christine) (Entered: 03/15/2011)
442011-03-15 REPLY MEMORANDUM in Support re 20 Motion for Limited Expedited Discovery filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Murawski, Michael) Modified text on 3/16/2011 (Duong, Diep). (Entered: 03/15/2011)
452011-03-15 REPLY DECLARATION re 44 Memorandum in Support of Motion by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Murawski, Michael) (Entered: 03/15/2011)
462011-03-15 Judge Nathaniel M. Gorton: ORDER entered. PROTECTIVE ORDER "Subject, specifically, to the provisions of Local Rule 7.2." (Duong, Diep) (Entered: 03/16/2011)
472011-03-31 Joint MOTION For Entry of Scheduling Order by Momenta Pharmaceuticals, Inc., Sandoz Inc., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A)(Murawski, Michael) (Entered: 03/31/2011)
482011-04-05 Judge Nathaniel M. Gorton: ENDORSED ORDER entered granting 47 Motion for Entry of Scheduling Order (Duong, Diep) (Entered: 04/06/2011)
492011-04-05 Judge Nathaniel M. Gorton: ORDER entered. SCHEDULING ORDER for Patent Infringement Cases. Preliminary Disclosure of the Claims Infringed due by 4/15/2011. Reply to Claim Construction Brief due by 11/10/2011. Joint Claim Construction and Prehearing Statement due by 11/23/2011. (Duong, Diep) (Entered: 04/06/2011)
502011-04-26 NOTICE of Appearance by Kara B. Coen on behalf of Momenta Pharmaceuticals, Inc. (Coen, Kara) (Entered: 04/26/2011)
512011-04-26 NOTICE of Appearance by Jessica Gan Lee on behalf of Momenta Pharmaceuticals, Inc. (Lee, Jessica) (Entered: 04/26/2011)
522011-07-05 MOTION for Leave to Disclose Confidential Information to Expert, Dr. Robert Linhardt by Teva Pharmaceuticals USA, Inc..(Rehnquist, James) (Entered: 07/05/2011)
532011-07-05 MEMORANDUM in Support re 52 MOTION for Leave to Disclose Confidential Information to Expert, Dr. Robert Linhardt filed by Teva Pharmaceuticals USA, Inc.. (Rehnquist, James) (Entered: 07/05/2011)
542011-07-05 DECLARATION re 52 MOTION for Leave to Disclose Confidential Information to Expert, Dr. Robert Linhardt (Declaration of Dr. Robert Linhardt in Support of Defendant's Motion for Leave to Disclose Confidential Information to its Expert, Dr. Robert Linhardt) by Teva Pharmaceuticals USA, Inc.. (Rehnquist, James) (Entered: 07/05/2011)
552011-07-05 DECLARATION re 52 MOTION for Leave to Disclose Confidential Information to Expert, Dr. Robert Linhardt (Declaration of Emily L. Rapalino in Support of Defendant's Motion for Leave to Disclose Confidential Information to its Expert, Dr. Robert Linhardt) by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J)(Rehnquist, James) (Entered: 07/05/2011)
562011-07-19 Opposition re 52 MOTION for Leave to Disclose Confidential Information to Expert, Dr. Robert Linhardt by Plaintiffs filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Lee, Jessica) (Entered: 07/19/2011)
572011-07-19 AFFIDAVIT of Dr. Ishan Capila in Opposition re 52 MOTION for Leave to Disclose Confidential Information to Expert, Dr. Robert Linhardt by Plaintiffs filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Lee, Jessica) (Entered: 07/19/2011)
582011-07-19 AFFIDAVIT of Jessica Gan Lee in Opposition re 52 MOTION for Leave to Disclose Confidential Information to Expert, Dr. Robert Linhardt filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit 1 to the Declaration of Jessica Gan Lee, # 2 Exhibit 2 to the Declaration of Jessica Gan Lee, # 3 Exhibit 3 to the Declaration of Jessica Gan Lee, # 4 Exhibit 4 to the Declaration of Jessica Gan Lee)(Lee, Jessica) (Entered: 07/19/2011)
592011-08-24 Letter/request (non-motion) from James C. Rehnquist. (Russo, Noreen) (Entered: 09/13/2011)
602011-10-03 Letter/request (non-motion) from James C. Rehnquist. (Rehnquist, James) (Entered: 10/03/2011)
612011-10-25 Assented to MOTION to Amend 49 Supplemental Scheduling Order for Patent Infringement Cases, by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A, # 2 Text of Proposed Order)(Lee, Jessica) (Entered: 10/25/2011)
622011-11-03 MOTION to Continue The Claim Construction Schedule (Unopposed) by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Blais, Elaine) (Entered: 11/03/2011)
632011-11-07 Judge Nathaniel M. Gorton: ENDORSED ORDER entered granting 62 Motion to Continue the Claim Construction Schedule by Teva Pharmaceuticals USA, Inc. (Moore, Kellyann) (Entered: 11/08/2011)
642012-02-07 Assented to MOTION to Amend 49 Supplemental Scheduling Order for Patent Infringement Cases, by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A)(Blais, Elaine) (Entered: 02/07/2012)
652012-02-15 NOTICE of Appearance by G. Mark Edgarton on behalf of Momenta Pharmaceuticals, Inc. (Edgarton, G.) (Entered: 02/15/2012)
662012-03-13 NOTICE of Appearance by Daniel C. Winston on behalf of Momenta Pharmaceuticals, Inc. (Winston, Daniel) (Entered: 03/13/2012)
672012-03-15 Judge Nathaniel M. Gorton: ENDORSED ORDER entered granting 64 Motion to Amend 49 Supplemental Scheduling Order for Patent Infringement Cases, by Teva Pharmaceuticals USA, Inc (Moore, Kellyann) (Entered: 03/15/2012)
682012-03-26 MOTION to Amend Claim Construction Briefing Page Limits (UNOPPOSED) by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Blais, Elaine) (Entered: 03/26/2012)
692012-03-27 MOTION for Leave to File Separate Briefs for Each Patent in Support of Their Claim Construction of U.S. Patent Nos. 7,790,466 and 7,575,886 by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Murawski, Michael) (Entered: 03/27/2012)
702012-03-27 Markman Brief by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Murawski, Michael) (Entered: 03/27/2012)
712012-03-27 Preliminary Claim Construction Briefs by Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) (Entered: 03/27/2012)
722012-03-27 DECLARATION re 71 Preliminary Claim Construction Briefs of Dr. Robert Linhardt, Ph.D. by Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) (Entered: 03/27/2012)
732012-03-27 DECLARATION re 71 Preliminary Claim Construction Briefs of Elaine Herrmann Blais by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5 (Part 1), # 6 Exhibit 5 (Part 2), # 7 Exhibit 5 (Part 3), # 8 Exhibit 6, # 9 Exhibit 7, # 10 Exhibit 8, # 11 Exhibit 9, # 12 Exhibit 10, # 13 Exhibit 11, # 14 Exhibit 12, # 15 Exhibit 13, # 16 Exhibit 14, # 17 Exhibit 15, # 18 Exhibit 16)(Blais, Elaine) (Entered: 03/27/2012)
742012-03-27 Markman Brief by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Murawski, Michael) (Entered: 03/27/2012)
752012-03-27 DECLARATION of Dr. Thomas C. Crawford, Ph.D. in Support of Plaintiffs' Claim Construction Memoranda Regarding US Patent Nos 7,790,466 and 7,575,886 by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Murawski, Michael) (Entered: 03/27/2012)
762012-03-27 DECLARATION of Michael E Murawski in Support of Plaintiffs' Claim Construction of US Patent Nos 7,790,466 and 7,575,886 by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10)(Murawski, Michael) (Entered: 03/27/2012)
772012-03-29 Opposition re 69 MOTION for Leave to File Separate Briefs for Each Patent in Support of Their Claim Construction of U.S. Patent Nos. 7,790,466 and 7,575,886 filed by Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) (Entered: 03/29/2012)
782012-03-30 Assented to MOTION for Leave to File [Proposed] Plaintiffs' Momenta Pharmaceuticals, Inc. and Sandoz Inc.'s Reply to Defendants' Oppositions to Plaintiffs' Motion for Leave to File Separate Claim Construction Briefs by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A [Proposed Reply Brief])(Murawski, Michael) (Entered: 03/30/2012)
792012-04-02 MEMORANDUM in Support re 69 MOTION for Leave to File Separate Briefs for Each Patent in Support of Their Claim Construction of U.S. Patent Nos. 7,790,466 and 7,575,886 [Plaintiffs Momenta Pharmaceuticals, Inc. and Sandoz Inc.'s Reply to Defendants' Oppositions to Plaintiffs' Motion for Leave to File Separate Claim Construction Briefs] filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Murawski, Michael) (Entered: 04/02/2012)
802012-04-04 Judge Nathaniel M. Gorton: ORDER entered granting 69 Motion for Leave to File Separate Briefs for Each Patent in Support of Claim Construction. "Motion allowed; deadlines are extended as follows: reply briefs shall be filed on or before Fri., April 13, 2012, joint statement shall be filed on or before Fri., April 20, 2012." Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Patch, Christine) (Entered: 04/09/2012)
812012-04-09 Markman Brief by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Murawski, Michael) (Entered: 04/09/2012)
822012-04-09 Markman Brief by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Murawski, Michael) (Entered: 04/09/2012)
832012-04-13 Reply to Preliminary Claim Construction Briefs by Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) Modified on 4/17/2012 to correct event used. (Moore, Kellyann). (Entered: 04/13/2012)
842012-04-13 DECLARATION re 83 Markman Brief (of Elaine Herrmann Blais) by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4)(Blais, Elaine) (Entered: 04/13/2012)
852012-04-13 Reply to Preliminary Claim Construction Briefs by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Marandett, Eric) (Entered: 04/13/2012)
862012-04-13 DECLARATION re 83 Markman Brief (of Dr. Robert Linhardt, Ph.D.) by Teva Pharmaceuticals USA, Inc.. (Blais, Elaine) (Entered: 04/13/2012)
872012-04-13 DECLARATION of Dr. Zachary Shriver, Ph.D., In Support of Plaintiffs Momenta Pharmaceuticals, Inc. and Sandoz, Inc.'s Reply Claim Construction Memoranda Regarding U.S. Patent Nos. 7,790,466 and 7,575,886 by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit Ex. A)(Marandett, Eric) (Entered: 04/13/2012)
882012-04-13 Reply to Preliminary Claim Construction Briefs by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Marandett, Eric) (Entered: 04/13/2012)
892012-04-13 DECLARATION of Michael E. Murawski, Esq., In Support of Plaintiffs Momenta Pharmaceuticals, Inc. and Sandoz, Inc.'s Reply Claim Construction Memoranda Regarding U.S. Patent Nos. 7,790,466 and 7,575,886 by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit Ex. 11, # 2 Exhibit Ex. 12, # 3 Exhibit Ex. 13, # 4 Exhibit Ex. 14)(Marandett, Eric) (Entered: 04/13/2012)
902012-04-13 EXHIBIT re 89 Declaration, Exhibit 15 by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Marandett, Eric) (Main Document 90 replaced on 4/17/2012) (Moore, Kellyann). (Entered: 04/13/2012)
912012-04-13 EXHIBIT re 89 Declaration, Exhibit 16 by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Marandett, Eric) (Entered: 04/13/2012)
922012-04-13 EXHIBIT re 89 Declaration, Exhibit 17 by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Marandett, Eric) (Entered: 04/13/2012)
932012-04-13 EXHIBIT re 89 Declaration, Exhibit 18 by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Marandett, Eric) (Entered: 04/13/2012)
942012-04-20 MOTION to Increase the Time Allotted for the Joint Markman Hearing by Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Blais, Elaine) (Entered: 04/20/2012)
952012-04-23 RESPONSE to Motion re 94 MOTION to Increase the Time Allotted for the Joint Markman Hearing [Plaintiffs' Response to Teva's Motion to Increase the Time Allotted for the Joint Markman Hearing] filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Murawski, Michael) (Entered: 04/23/2012)
962012-04-23 Joint Claim Construction and Prehearing Statement by Momenta Pharmaceuticals, Inc., Sandoz Inc., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Exhibit A - US Patent No 7,575,886, # 2 Exhibit B - US Patent No 7,790,466)(Murawski, Michael) (Entered: 04/23/2012)
972012-04-25 Judge Nathaniel M. Gorton: ENDORSED ORDER entered granting in part and denying in part 94 MOTION to Increase the Time Allotted for the Joint Markman Hearing by Teva Pharmaceuticals USA, Inc.. "Motion allowed, in part and denied, in part: a total of 5 hours is allotted, 2 1/4 hours to plaintiffs and 2 3/4 hours to defendants (to be divided between them as agreed)." (Moore, Kellyann) (Entered: 04/25/2012)
982012-04-30 MOTION Plaintiffs' Motion to Preclude Teva's Use of Expert Testimony to Support its Indefiniteness Defense at the Markman Hearing by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Murawski, Michael) (Main Document 98 replaced on 4/30/2012) (Moore, Kellyann). (Entered: 04/30/2012)
992012-05-03 STIPULATION Regarding Teva's Indefiniteness Argument by Momenta Pharmaceuticals, Inc., Sandoz Inc., Teva Pharmaceuticals USA, Inc.. (Attachments: # 1 Text of Proposed Order)(Blais, Elaine) (Entered: 05/03/2012)
1002012-05-03 Judge Nathaniel M. Gorton: ORDER entered re 99 Stipulation re: Defendants' Indefiniteness Arguments filed by Momenta Pharmaceuticals, Inc., Sandoz Inc., Teva Pharmaceuticals USA, Inc. (Patch, Christine) (Entered: 05/03/2012)
1012012-05-10 Transcript of Markman Hearing held on May 4, 2012, before Judge Nathaniel M. Gorton. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Cheryl Dahlstrom at 617-951-4555 Redaction Request due 5/31/2012. Redacted Transcript Deadline set for 6/11/2012. Release of Transcript Restriction set for 8/8/2012. (Scalfani, Deborah) (Entered: 05/10/2012)
1022012-06-01 NOTICE of Appearance by Sophie F. Wang on behalf of Momenta Pharmaceuticals, Inc. (Wang, Sophie) (Entered: 06/01/2012)
1032012-06-06 Transcript of Motion Hearing held on June 4, 2012, before Magistrate Judge Robert B. Collings. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Helana Kline at [email protected] Redaction Request due 6/27/2012. Redacted Transcript Deadline set for 7/9/2012. Release of Transcript Restriction set for 9/4/2012. (Scalfani, Deborah) (Main Document 103 replaced on 6/6/2012) (Scalfani, Deborah). (Entered: 06/06/2012)
1042012-06-06 Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Joshua A. Whitehill Filing fee: $ 100, receipt number 0101-3975866 by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A)(Blais, Elaine) (Entered: 06/06/2012)
1052012-06-07 Joint MOTION to Continue Mediation Scheduled for June 20, 2012 by Momenta Pharmaceuticals, Inc., Sandoz Inc., Teva Pharmaceuticals USA Inc.(Edgarton, G.) (Entered: 06/07/2012)
1062012-06-14 Assented to MOTION to Amend the Scheduling Order by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A)(Blais, Elaine) (Entered: 06/14/2012)
1072012-06-15 Judge Nathaniel M. Gorton: ORDER entered granting 106 Assented to MOTION to Amend the Scheduling Order by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Entered: 06/18/2012)
1082012-06-27 Judge Nathaniel M. Gorton: ORDER entered. MEMORANDUM AND ORDER(Moore, Kellyann) (Entered: 06/27/2012)
1092012-07-03 MOTION for Clarification re 108 Memorandum & ORDER or Modification of Order on Claim Construction by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Murawski, Michael) (Entered: 07/03/2012)
1102012-07-09 Opposition re 109 MOTION for Clarification re 108 Memorandum & ORDER or Modification of Order on Claim Construction filed by Teva Pharmaceuticals USA Inc. (Rehnquist, James) (Entered: 07/09/2012)
1112012-07-31 Judge Nathaniel M. Gorton: ORDER entered granting 109 Motion for Clarification re 108 Memorandum & ORDER (Patch, Christine) (Entered: 07/31/2012)
1122012-08-03 Assented to MOTION for Leave to Appear Pro Hac Vice for admission of Daniel B. Reagan Filing fee: $ 100, receipt number 0101-4056998 by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Certification of Daniel B. Reagan)(Blais, Elaine) (Entered: 08/03/2012)
1132012-08-03 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 112 Motion for Leave to Appear Pro Hac Vice Added Daniel B. Reagan. Attorneys admitted Pro Hac Vice must register for electronic filing if the attorney does not already have an ECF account in this district. To register go to the Court website at www.mad.uscourts.gov. Select Case Information, then Electronic Filing (CM/ECF) and go to the CM/ECF Registration Form. (Moore, Kellyann) (Entered: 08/03/2012)
1142012-08-10 Joint MOTION to Stay Litigation by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Appendix)(Murawski, Michael) (Entered: 08/10/2012)
1152012-08-14 Judge Nathaniel M. Gorton: ENDORSED ORDER entered granting 114 Motion to Stay Litigation by Momenta Pharmaceuticals, Inc., Sandoz Inc. " Motion allowed, provided however that counsel shall file interim joint status reports on Nov. 15, 2012, and every 90 days thereafter.All pending Motions are denied without prejudice." (Moore, Kellyann) Modified on 8/15/2012 (Patch, Christine). (Entered: 08/15/2012)
1162012-09-10 Assented to MOTION to Withdraw Appearance of Adam R. Wichman by Teva Pharmaceuticals USA Inc.(Blais, Elaine) (Entered: 09/10/2012)
1172012-09-11 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 116 Motion to Withdraw as Counsel. (Patch, Christine) (Entered: 09/11/2012)
1182012-10-19 NOTICE of Change of Address or Firm Name by Sarah Chapin Columbia for McDermott Will & Emery LLP's Washington, DC Office (Columbia, Sarah) (Entered: 10/19/2012)
1192012-11-14 STATUS REPORT Interim Joint by Momenta Pharmaceuticals, Inc., Sandoz Inc., Teva Pharmaceutical Industries, Ltd., Teva Pharmaceuticals USA Inc, Teva Pharmaceuticals USA, Inc.. (Murawski, Michael) (Entered: 11/14/2012)
1202012-12-06 MOTION to Remove Stay by Teva Pharmaceuticals USA Inc.(Blais, Elaine) (Entered: 12/06/2012)
1212012-12-20 Opposition re 120 MOTION to Remove Stay filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Winston, Daniel) (Main Document 121 replaced on 12/21/2012) (Moore, Kellyann). (Additional attachment(s) added on 12/21/2012: # 1 Exhibit A) (Moore, Kellyann). (Entered: 12/20/2012)
1222012-12-27 MOTION for Leave to File a Reply to Plaintiffs' Opposition to Teva's Motion to Remove Stay by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A - Proposed Reply)(Blais, Elaine) (Entered: 12/27/2012)
1232012-12-28 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered denying 122 Motion for Leave to File Document (Patch, Christine) (Entered: 12/28/2012)
1242013-01-15 Notice of Supplemental Authorities re 120 MOTION to Remove Stay (Attachments: # 1 Exhibit A)(Blais, Elaine) (Entered: 01/15/2013)
1252013-01-15 Judge Nathaniel M. Gorton: ENDORSED ORDER entered granting 120 MOTION to Remove Stay by Teva Pharmaceuticals USA Inc. "Motion allowed." (Moore, Kellyann) (Entered: 01/15/2013)
1262013-01-16 ELECTRONIC NOTICE of Hearing. Status Conference set for 1/24/2013 11:30 AM in Courtroom 4 before Judge Nathaniel M. Gorton. (Patch, Christine) (Entered: 01/16/2013)
1272013-01-22 NOTICE re 126 Notice of Hearing. Parties are to notify the Deputy Clerk by email ([email protected]) as to which attorneys will be present, and for which party they represent, for the Status Conference scheduled for Thursday, January 24, 2013 at 11:30 AM. (Patch, Christine) (Entered: 01/22/2013)
1282013-01-24 ELECTRONIC Clerk's Notes for proceedings held before Judge Nathaniel M. Gorton: Status Conference held on 1/24/2013. Defendant Teva to file Motion for Summary Judgment by 1/31/2013. Counsel discuss status of case and outstanding discovery matters. Plaintiff to file a Motion explaining what discovery matters are pending and still viable by 1/31/13 in Amphastar case (11cv11681-NMG). Defendant Amphastar to respond by 2/14/13. Court will take the matter under advisement. If resolved, Plaintiff to respond to Motion for Summary Judgment by 3/21/2013. Motion Hearing, if necessary, set for 5/3/2013 02:30 PM in Courtroom 4 before Judge Nathaniel M. Gorton. (Court Reporter: Cheryl Dahlstrom at [email protected])(Attorneys present: Frank, Winston, Murawski, Blais, Rehnquist, Frederickson,) (Patch, Christine) Modified on 1/24/2013 to correct response date for Motion for Summary Judgment (Patch, Christine). (Entered: 01/24/2013)
1292013-01-25 Transcript of Status Conference held on January 24, 2013, before Judge Nathaniel M. Gorton. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Cheryl Dahlstrom at [email protected] Redaction Request due 2/15/2013. Redacted Transcript Deadline set for 2/25/2013. Release of Transcript Restriction set for 4/25/2013. (Scalfani, Deborah) (Entered: 01/25/2013)
1302013-01-25 NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Scalfani, Deborah) (Entered: 01/25/2013)
1312013-01-25 Assented to MOTION to Withdraw as Attorney Kara B. Coen by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Murawski, Michael) (Entered: 01/25/2013)
1322013-01-28 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 131 Motion to Withdraw as Attorney. Attorney Kara B. Coen terminated (Patch, Christine) (Entered: 01/28/2013)
1332013-01-30 Assented to MOTION to Seal Teva Pharmaceticals USA, Inc.'s Summary Judgment Filings by Teva Pharmaceuticals USA Inc.(Blais, Elaine) (Entered: 01/30/2013)
1342013-01-31 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 133 Motion to Seal Summary Judgment filings. (Patch, Christine) (Entered: 01/31/2013)
1352013-01-31 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds by Teva Pharmaceuticals USA Inc.(Rehnquist, James) (Entered: 01/31/2013)
1362013-01-31 NOTICE OF MANUAL FILING by Teva Pharmaceuticals USA Inc (Rehnquist, James) (Entered: 01/31/2013)
1372013-01-31 SEALED MEMORANDUM in Support re 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds filed by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Entered: 02/01/2013)
1382013-01-31 SEALED Statement of Material Facts L.R. 56.1 re 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds filed by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Entered: 02/01/2013)
1392013-01-31 SEALED DECLARATION of Philip Erickson by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Entered: 02/01/2013)
1402013-01-31 SEALED DECLARATION of Dr. Gianni Marcacci by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Entered: 02/01/2013)
1412013-01-31 SEALED Appendix of Exhibits in support of 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Additional attachment(s) added on 2/1/2013: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G part 1, # 8 Exhibit G part 2, # 9 Exhibit G part 3, # 10 Exhibit G part 4, # 11 Exhibit G part 5, # 12 Exhibit G part 6, # 13 Exhibit H, # 14 Exhibit I, # 15 Exhibit J, # 16 Exhibit K, # 17 Exhibit L, # 18 Exhibit M, # 19 Exhibit N, # 20 Exhibit O, # 21 Exhibit P, # 22 Exhibit R, # 23 Exhibit S, # 24 Exhibit T, # 25 Exhibit U) (Moore, Kellyann). (Entered: 02/01/2013)
1422013-03-15 Assented to MOTION to Seal Filings in Support of Teva Pharmaceuticals USA, Inc.'s Motion to Strike by Teva Pharmaceuticals USA Inc.(Blais, Elaine) (Entered: 03/15/2013)
1432013-03-18 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 142 Motion to Seal (Patch, Christine) (Entered: 03/18/2013)
1442013-03-18 MOTION to Strike Plaintiffs' Third Amended Infringement Contentions by Teva Pharmaceuticals USA Inc.(Blais, Elaine) (Entered: 03/18/2013)
1452013-03-18 NOTICE OF MANUAL FILING by Teva Pharmaceuticals USA Inc (Blais, Elaine) (Entered: 03/18/2013)
1462013-03-19 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered. REFERRING CASE to Magistrate Judge Robert B. Collings Referred for: Events Only (e). Motions referred: 144 MOTION to Strike Plaintiffs' Third Amended Infringement Contentions. (Patch, Christine) Motions referred to Robert B. Collings. (Entered: 03/19/2013)
1472013-03-18 SEALED MEMORANDUM in Support re 144 MOTION to Strike Plaintiffs' Third Amended Infringement Contentions filed by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Entered: 03/19/2013)
1482013-03-18 SEALED DECLARATION of Robert Frederickson in support of 144 MOTION to Strike Plaintiffs' Third Amended Infringement Contentions by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A part 1, # 2 Exhibit A part 2, # 3 Exhibit A part 3, # 4 Exhibit B, # 5 Exhibit C, # 6 Exhibit D, # 7 Exhibit E, # 8 Exhibit F, # 9 Exhibit G, # 10 Exhibit H)(Moore, Kellyann) (Entered: 03/19/2013)
1492013-03-21 MOTION to Reset Summary Judgment Briefing Deadlines by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Wang, Sophie) (Entered: 03/21/2013)
1502013-03-21 Opposition re 149 MOTION to Reset Summary Judgment Briefing Deadlines filed by Teva Pharmaceuticals USA Inc. (Frederickson, Robert) (Entered: 03/21/2013)
1512013-04-01 Judge Nathaniel M. Gorton: ENDORSED ORDER entered denying 149 MOTION to Reset Summary Judgment Briefing Deadlines by Momenta Pharmaceuticals, Inc., Sandoz Inc. "Motion denied; plaintiffs' opposition to defendant's motion for summary judgment (Docket No. 135 ) shall be filed at or before the close of business on Fri., April 5, 2013." (Moore, Kellyann) (Entered: 04/01/2013)
1522013-04-01 Set/Reset Deadlines as to 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds. Plaintiff's opposition due by 4/5/2013. (Moore, Kellyann) (Entered: 04/01/2013)
1532013-04-01 MOTION to Seal Document by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Lee, Jessica) (Entered: 04/01/2013)
1542013-04-02 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered. REFERRING MOTION 153 MOTION to Seal Document filed by Momenta Pharmaceuticals, Inc., Sandoz Inc. to Magistrate Judge Collings(Patch, Christine) Motions referred to Robert B. Collings. (Entered: 04/02/2013)
1552013-04-05 Assented to MOTION to Seal Documents Related to Plaintiffs' Opposition to Defendant's Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Wang, Sophie) (Entered: 04/05/2013)
1562013-04-05 DECLARATION of William W. Vodra In Support of Plaintiffs' Opposition to Summary Judgment by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A)(Wang, Sophie) (Entered: 04/05/2013)
1572013-04-08 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 155 Motion to Seal (Patch, Christine) (Entered: 04/08/2013)
1582013-04-12 Assented to MOTION to Seal Teva Pharmaceuticals USA, Inc.'s Opposition to Plaintiff's Motion for Leave to Amend its Infringement Contentions by Teva Pharmaceuticals USA Inc.(Blais, Elaine) (Entered: 04/12/2013)
1592013-04-12 NOTICE OF MANUAL FILING by Teva Pharmaceuticals USA Inc (Blais, Elaine) (Entered: 04/12/2013)
1602013-04-16 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 158 Motion to Seal (Patch, Christine) (Entered: 04/16/2013)
1612013-04-16 SEALED Cross-MOTION for leave to Amend Infringement Contentions by Momenta Pharmaceuticals, Inc., Sandoz Inc.(Moore, Kellyann) (Entered: 04/16/2013)
1622013-04-16 SEALED MEMORANDUM in Opposition re 144 MOTION to Strike Plaintiffs' Third Amended Infringement Contentions filed by Momenta Pharmaceuticals, Inc., Sandoz Inc. (Moore, Kellyann) (Entered: 04/16/2013)
1632013-04-16 SEALED DECLARATION of Jessica Gan Lee, Esq in support 162 Memorandum in Opposition to Motion by Momenta Pharmaceuticals, Inc., Sandoz Inc. (Moore, Kellyann) (Additional attachment(s) added on 4/16/2013: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20) (Moore, Kellyann). (Entered: 04/16/2013)
1642013-04-16 SEALED MEMORANDUM in Opposition re 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds filed by Momenta Pharmaceuticals, Inc., Sandoz Inc. (Attachments: # 1 Appendix)(Moore, Kellyann) (Entered: 04/16/2013)
1652013-04-16 Plaintiffs' SEALED Response to 138 SEALED Statement of Material Facts L.R. 56.1 re [135 ]MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds filed by Teva Pharmaceuticals USA Inc.(Moore, Kellyann) (Entered: 04/16/2013)
1662013-04-16 SEALED DECLARATION in support of 164 SEALED MEMORANDUM in Opposition re 135 MOTION for Summary Judgment. (Moore, Kellyann) (Entered: 04/16/2013)
1672013-04-16 SEALED DECLARATION in support of 164 SEALED MEMORANDUM in Opposition re 135 MOTION for Summary Judgment. (Attachments: # 1 Exhibit A)(Moore, Kellyann) (Entered: 04/16/2013)
1682013-04-16 SEALED Declaration in support of 164 SEALED MEMORANDUM in Opposition re 135 Motion for Summary Judgment. (Moore, Kellyann) (Additional attachment(s) added on 4/16/2013: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10) (Moore, Kellyann). (Additional attachment(s) added on 4/16/2013: # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20) (Moore, Kellyann). (Additional attachment(s) added on 4/16/2013: # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27, # 28 Exhibit 28) (Moore, Kellyann). (Additional attachment(s) added on 4/16/2013: # 29 Exhibit 29 part 1, # 30 Exhibit 29 part 2, # 31 Exhibit 30) (Moore, Kellyann). (Additional attachment(s) added on 4/16/2013: # 32 Exhibit 31 part 1, # 33 Exhibit 31 part 2, # 34 Exhibit 31 part 3, # 35 Exhibit 31 part 4, # 36 Exhibit 31 part 5, # 37 Exhibit 31 part 6) (Moore, Kellyann). (Additional attachment(s) added on 4/16/2013: # 38 Exhibit 31 part 7, # 39 Exhibit 31 part 8, # 40 Exhibit 31 part 9, # 41 Exhibit 31 part 10) (Moore, Kellyann). (Additional attachment(s) added on 4/16/2013: # 42 Exhibit 32, # 43 Exhibit 33, # 44 Exhibit 34, # 45 Exhibit 35, # 46 Exhibit 36, # 47 Exhibit 37, # 48 Exhibit 38, # 49 Exhibit 39, # 50 Exhibit 40, # 51 Exhibit 41, # 52 Exhibit 42, # 53 Exhibit 43) (Moore, Kellyann). (Additional attachment(s) added on 4/16/2013: # 54 Exhibit 44 part 1, # 55 Exhibit 44 part 2, # 56 Exhibit 45) (Moore, Kellyann). (Entered: 04/16/2013)
1692013-04-16 SEALED Opposition re 161 MOTION to Amend filed by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Entered: 04/16/2013)
1702013-04-17 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered. REFERRING MOTION 161 MOTION to Amend filed by Momenta Pharmaceuticals, Inc., Sandoz Inc. to Magistrate Judge Collings(Patch, Christine) Motions referred to Robert B. Collings. (Entered: 04/17/2013)
1712013-04-18 Assented to MOTION for Extension of Time to April 25, 2013 to File a Reply in Support of its January 31, 2013 Motion for Judgment on the Pleadings, or in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Text of Proposed Order)(Frederickson, Robert) (Entered: 04/18/2013)
1722013-04-22 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered. re 170 Order Referring 161 Motion to MJ Collings. Motion will remain before Judge Gorton. (Patch, Christine) (Entered: 04/22/2013)
1732013-04-22 Motions No Longer Referred to Magistrate Judge: 161 MOTION to Amend (Patch, Christine) (Entered: 04/22/2013)
1742013-04-25 Assented to MOTION for Leave to File a Reply in Support of its January 31, 2013 Motion for Judgment on the Pleadings, or in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds by Teva Pharmaceuticals USA Inc.(Frederickson, Robert) (Entered: 04/25/2013)
1752013-04-25 Assented to MOTION to Seal Reply in Support of its Motion for Judgment on the Pleadings, or in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds by Teva Pharmaceuticals USA Inc.(Frederickson, Robert) (Entered: 04/25/2013)
1762013-04-25 APPENDIX/EXHIBIT (Supplemental Appendix of Exhibits in Support of Teva Pharmaceuticals USA, Inc.'s Motion for Summary Judgment) by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit V, # 2 Exhibit W, # 3 Exhibit X)(Rehnquist, James) (Entered: 04/25/2013)
1772013-04-25 NOTICE OF MANUAL FILING by Teva Pharmaceuticals USA Inc (Rehnquist, James) (Entered: 04/25/2013)
1782013-04-26 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting in part 174 Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. REPLY MEMO NOT TO EXCEED 10 PAGES; granting 175 Motion to Seal (Patch, Christine) (Entered: 04/26/2013)
1792013-04-26 Assented to MOTION for Leave to File Reply to Teva's Opposition to Plaintiffs' Motion For Leave to Amend Infringement Contentions by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Wang, Sophie) (Entered: 04/26/2013)
1802013-04-26 Assented to MOTION to Seal Plaintiffs' Reply to Teva's Opposition to Plaintiffs' Motion For Leave to Amend Infringement Contentions by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Wang, Sophie) (Entered: 04/26/2013)
1812013-04-26 Emergency MOTION to Intervene for the Limited Purpose of Receiving a Redacted Version of Plaintiffs' Opposition Papers to Teva's Motion for Summary Judgment by Amphastar Pharmaceuticals, Inc..(Foss, Taylor) (Entered: 04/26/2013)
1822013-04-29 ELECTRONIC NOTICE Resetting Hearing on Motion 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds : Motion Hearing set for 5/17/2013 10:00 AM in Courtroom 4 before Judge Nathaniel M. Gorton. (Patch, Christine) (Entered: 04/29/2013)
1832013-04-29 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting in part 179 Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. REPLY MEMO NOT TO EXCEED 10 PAGES; granting 180 Motion to Seal (Patch, Christine) (Entered: 04/29/2013)
1842013-04-29 SEALED REPLY in support of 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds filed by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Entered: 04/29/2013)
1852013-04-29 SEALED REPLY to Response to 161 SEALED Cross-MOTION for leave to Amend Infringement Contentions by Momenta Pharmaceuticals, Inc., Sandoz Inc. (Moore, Kellyann) (Entered: 04/29/2013)
1862013-05-01 ELECTRONIC NOTICE Resetting Hearing on Motion 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds : Motion Hearing set for 8/8/2013 11:30 AM in Courtroom 4 before Judge Nathaniel M. Gorton. (Patch, Christine) (Entered: 05/01/2013)
1872013-05-02 ELECTRONIC NOTICE Resetting Hearing on Motion 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds : Motion Hearing set for 7/1/2013 11:30 AM in Courtroom 4 before Judge Nathaniel M. Gorton. (Patch, Christine) (Entered: 05/02/2013)
1882013-05-02 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered finding as moot 171 Motion for Extension of Time to File (Patch, Christine) (Entered: 05/02/2013)
1892013-05-10 Assented to MOTION for Leave to File A Surreply In Opposition to Teva's Motion for Summary Judgment by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Wang, Sophie) (Entered: 05/10/2013)
1902013-05-10 Assented to MOTION to Seal Plaintiffs' Surreply In Opposition to Teva's Motion for Summary Judgment and Supporting Documents by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Wang, Sophie) (Entered: 05/10/2013)
1912013-05-10 Opposition re 181 Emergency MOTION to Intervene for the Limited Purpose of Receiving a Redacted Version of Plaintiffs' Opposition Papers to Teva's Motion for Summary Judgment filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Murawski, Michael) (Entered: 05/10/2013)
1922013-05-10 DECLARATION of Michael E. Murawski, Esq., In Support of Plaintiffs' Opposition to Amphastar's Motion to Intervene by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit 1)(Murawski, Michael) (Entered: 05/10/2013)
1932013-05-13 MOTION for Leave to File Reply in Support of Motion to Intervene for the Limited Purpose of Receiving a Redacted Version of Plaintiffs' Opposition Papers to Teva Pharmaceutical USA, Inc.'s Motion for Summary Judgment by Amphastar Pharmaceuticals, Inc.. (Attachments: # 1 Exhibit A)(Foss, Taylor) (Entered: 05/13/2013)
1942013-05-13 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered denying 189 Motion for Leave to File Document ; finding as moot 190 Motion to Seal (Patch, Christine) (Entered: 05/13/2013)
1952013-05-14 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 193 Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Patch, Christine) (Entered: 05/14/2013)
1962013-05-14 REPLY to Response to 181 Emergency MOTION to Intervene for the Limited Purpose of Receiving a Redacted Version of Plaintiffs' Opposition Papers to Teva's Motion for Summary Judgment filed by Amphastar Pharmaceuticals, Inc.. (Foss, Taylor) (Entered: 05/14/2013)
1972013-05-17 Judge Nathaniel M. Gorton: ENDORSED ORDER entered denying 181 Emergency MOTION to Intervene for the Limited Purpose of Receiving a Redacted Version of Plaintiffs' Opposition Papers to Teva's Motion for Summary Judgment by Amphastar Pharmaceuticals, Inc. "Motion denied." (Moore, Kellyann) (Entered: 05/20/2013)
1982013-04-02 Magistrate Judge Robert B. Collings: ENDORSED ORDER entered granting 153 Motion to File Documents Under Seal. (Dolan, Kathleen) (Entered: 06/24/2013)
1992013-06-24 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered re 146 Order Referring Case to Magistrate Judge Collings. Motion will remain before Judge Gorton. (Patch, Christine) (Entered: 06/24/2013)
2002013-06-24 Case no longer referred to Magistrate Judge Robert B. Collings. (Dolan, Kathleen) (Entered: 06/24/2013)
2012013-06-25 ELECTRONIC NOTICE Resetting Hearing on Motion 161 MOTION to Amend, 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds, 144 MOTION to Strike Plaintiffs' Third Amended Infringement Contentions : Motion Hearing set for 7/1/2013 11:00 AM in Courtroom 4 before Judge Nathaniel M. Gorton. NOTE - CHANGE IS AS TO TIME ONLY. (Patch, Christine) (Entered: 06/25/2013)
2022013-07-01 ELECTRONIC Clerk's Notes for proceedings held before Judge Nathaniel M. Gorton: Motion Hearing held on 7/1/2013 re 144 MOTION to Strike Plaintiffs' Third Amended Infringement Contentions filed by Teva Pharmaceuticals USA Inc, 161 MOTION to Amend filed by Momenta Pharmaceuticals, Inc., Sandoz Inc., 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds filed by Teva Pharmaceuticals USA Inc. Court hears arguments of counsel on the pending motions and will take all pending motions under advisement. (Court Reporter: Cheryl Dahlstrom at [email protected])(Attorneys present: Frank, Winston, Lee, Murawski, Wang, Steindler, Blais, Rehnquist, Frederickson,) (Patch, Christine) (Entered: 07/01/2013)
2032013-07-03 Transcript of Hearing on Motions held on July 1, 2013, before Judge Nathaniel M. Gorton. The Transcript may be purchased through the Court Reporter, viewed at the public terminal, or viewed through PACER after it is released. Court Reporter Name and Contact Information: Cheryl Dahlstrom at [email protected] Redaction Request due 7/24/2013. Redacted Transcript Deadline set for 8/5/2013. Release of Transcript Restriction set for 10/1/2013. (Scalfani, Deborah) (Entered: 07/03/2013)
2042013-07-03 NOTICE is hereby given that an official transcript of a proceeding has been filed by the court reporter in the above-captioned matter. Counsel are referred to the Court's Transcript Redaction Policy, available on the court website at http://www.mad.uscourts.gov/attorneys/general-info.htm (Scalfani, Deborah) (Entered: 07/03/2013)
2052013-07-19 Judge Nathaniel M. Gorton: ORDER entered. MEMORANDUM AND ORDER, granting 144 MOTION to Strike Plaintiffs' Third Amended Infringement Contentions filed by Teva Pharmaceuticals USA Inc, granting 135 MOTION for Summary Judgment (Teva Pharmaceuticals USA, Inc.'s Motion for Judgment on the Pleadings, or, in the Alternative, Summary Judgment of Non-Infringement on Safe Harbor Grounds filed by Teva Pharmaceuticals USA Inc, denying 161 MOTION to Amend filed by Momenta Pharmaceuticals, Inc., Sandoz Inc. (Patch, Christine) (Entered: 07/19/2013)
2062013-08-16 NOTICE OF APPEAL to the Federal Circuit as to 205 Memorandum & ORDER, Terminate Motions,,,, by Momenta Pharmaceuticals, Inc., Sandoz Inc. Filing fee: $ 455, receipt number 0101-4593892 Fee Status: Filing Fee paid. US District Court Clerk to deliver official record to Court of Appeals by 9/5/2013. (Frank, Robert) (Entered: 08/16/2013)
2072013-08-21 Certified and Transmitted Abbreviated Electronic Record on Appeal to US Court of Appeals for the Federal Circuit re 206 Notice of Appeal to the Federal Circuit, (Danieli, Chris) (Danieli, Chris). (Entered: 08/21/2013)
2082013-09-05 NOTICE of Withdrawal of Appearance by Michael E. Murawski Notice of Withdrawal of Appearance of Jessica Gan Lee (Murawski, Michael) (Entered: 09/05/2013)
2092013-11-14 MOTION for Entry of Final Judgment by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Proposed Judgment)(Blais, Elaine) (Entered: 11/14/2013)
209.1 Proposed Judgment
2102013-11-14 MEMORANDUM in Support re 209 MOTION for Entry of Final Judgment filed by Teva Pharmaceuticals USA Inc. (Blais, Elaine) (Entered: 11/14/2013)
2112013-11-21 ORDER of the USCA for the Federal Circuit as to 206 Notice of Appeal to the Federal Circuit. The appeal is dismissed for lack of jurisdiction, subject to reinstatement under the same docket number without the payment of an additional filing fee if, within 60 days of the date of this order, the district court enters final judgment and within 30 days of entry of judgment Momenta files another notice of appeal. All pending motions are denied as moot. Each side shall bear its own costs. (Paine, Matthew) (Entered: 11/21/2013)
2122013-11-27 Opposition re 209 MOTION for Entry of Final Judgment filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B)(Murawski, Michael) (Entered: 11/27/2013)
2132013-12-02 NOTICE of Withdrawal of Appearance by Robert Frederickson, III (Notice of Withdrawal of Appearance of Daniel B. Reagan) (Frederickson, Robert) (Entered: 12/02/2013)
2142013-12-06 MOTION for Leave to File a Reply in Support of its Request for Entry of Final Judgment (With Consent) by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A)(Blais, Elaine) (Entered: 12/06/2013)
2152013-12-09 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 214 Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Patch, Christine) (Entered: 12/09/2013)
2162013-12-09 Assented to MOTION to Seal Exhibits A-F to Declaration of Joshua A. Whitehill in Support of Teva's Reply in Support of its Motion for Entry of Final Judgment by Teva Pharmaceuticals USA Inc.(Blais, Elaine) (Entered: 12/09/2013)
2172013-12-09 REPLY to Response to 209 MOTION for Entry of Final Judgment filed by Teva Pharmaceuticals USA Inc. (Blais, Elaine) (Entered: 12/09/2013)
2182013-12-09 DECLARATION re 217 Reply to Response to Motion of Joshua A. Whitehill by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A - Filed Under Seal, # 2 Exhibit B - Filed Under Seal, # 3 Exhibit C - Filed Under Seal, # 4 Exhibit D - Filed Under Seal, # 5 Exhibit E - Filed Under Seal, # 6 Exhibit F - Filed Under Seal)(Blais, Elaine) (Entered: 12/09/2013)
2192013-12-09 NOTICE OF MANUAL FILING by Teva Pharmaceuticals USA Inc (Blais, Elaine) (Entered: 12/09/2013)
2202013-12-10 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 216 Motion to Seal (Patch, Christine) (Entered: 12/10/2013)
2212013-12-10 SEALED EXHIBITS A-F re 218 Declaration, by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit B, # 2 Exhibit C, # 3 Exhibit D, # 4 Exhibit E, # 5 Exhibit F)(Moore, Kellyann) (Entered: 12/10/2013)
2222013-12-30 MANDATE of USCA for the Federal Circuit as to 206 Notice of Appeal to the Federal Circuit, filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. Appeal 206 terminated... (Paine, Matthew) (Entered: 12/30/2013)
2232014-01-14 NOTICE OF APPEAL to the Federal Circuit as to 225 Order of Final Judgment by Momenta Pharmaceuticals, Inc., Sandoz Inc. Filing fee: $ 505, receipt number 0101-4813839 Fee Status: Filing Fee paid. US District Court Clerk to deliver official record to Court of Appeals by 2/3/2014. (Frank, Robert) Modified to update document link on 1/28/2014 (Moore, Kellyann). (Entered: 01/14/2014)
2242014-01-24 Judge Nathaniel M. Gorton: ORDER entered. MEMORANDUM AND ORDER: "For the foregoing reasons, defendant's motion for entry of final judgment (Docket No. 209 ) is, with respect to defendant's First Counterclaim for a declaratory judgment of non-infringement of U.S. Patent No. 7,790,466, DENIED, but is, in all other respects, ALLOWED. So ordered."(Moore, Kellyann) (Entered: 01/27/2014)
2252014-01-24 Judge Nathaniel M. Gorton: ORDER of FINAL JUDGMENT entered. (Moore, Kellyann) (Entered: 01/27/2014)
2262014-01-28 Certified and Transmitted Abbreviated Electronic Record on Appeal to US Court of Appeals for the Federal Circuit re 223 Notice of Appeal to the Federal Circuit (Paine, Matthew) (Entered: 01/28/2014)
2272014-01-30 NOTICE OF APPEAL to the Federal Circuit as to 205 Memorandum & ORDER, Terminate Motions,,,, 225 Judgment by Momenta Pharmaceuticals, Inc., Sandoz Inc. Filing fee: $ 505, receipt number 0101-4839342 Fee Status: Filing Fee paid. US District Court Clerk to deliver official record to Court of Appeals by 2/19/2014. (Frank, Robert) (Entered: 01/30/2014)
2282014-01-30 Certified and Transmitted Abbreviated Electronic Record on Appeal to US Court of Appeals for the Federal Circuit re 227 Notice of Appeal to the Federal Circuit, (Paine, Matthew) (Entered: 01/30/2014)
2292014-01-30 USCA for the Federal Circuit Case Number 14-1274 for 223 Notice of Appeal to the Federal Circuit, filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Paine, Matthew) (Entered: 02/03/2014)
2302014-01-31 USCA for the Federal Circuit Case Number 14-1277 for 227 Notice of Appeal to the Federal Circuit, filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Paine, Matthew) (Entered: 02/03/2014)
2312014-02-07 Assented to MOTION to Seal Teva's Memorandum in Support of its Motion for Attorney Fees Under 35 U.S.C. § 285 and Supporting Declaration by Teva Pharmaceuticals USA Inc.(Frederickson, Robert) (Entered: 02/07/2014)
2322014-02-10 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 231 Motion to Seal (Patch, Christine) (Entered: 02/10/2014)
2332014-02-10 MOTION for Attorney Fees Under 35 U.S.C. § 285 by Teva Pharmaceuticals USA Inc.(Blais, Elaine) (Entered: 02/10/2014)
2342014-02-10 NOTICE OF MANUAL FILING by Teva Pharmaceuticals USA Inc (1) Defendant Teva Pharmaceuticals USA, Inc.'s Memorandum in Support of Its Motion for Attorney Fees Under 35 U.S.C. § 285, including Appendix A thereto; and (2) Declaration of Elaine Herrmann Blais in Support of Defendant Teva Pharmaceuticals USA, Inc.'s Memorandum in Support of Its Motion for Attorney Fees Under 35 U.S.C. § 285, including Exhibits 1-34 thereto. re 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 (DOCUMENTS FILED UNDER SEAL) (Blais, Elaine) (Entered: 02/10/2014)
2352014-02-11 SEALED MEMORANDUM in Support re 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 filed by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Entered: 02/12/2014)
2362014-02-11 SEALED Declaration of Elaine Herrmann Blais in Support of 235 SEALED MEMORANDUM in Support re 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 filed by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4 (can't scan), # 5 Exhibit 5, # 6 Exhibit 6, # 7 Exhibit 7, # 8 Exhibit 8, # 9 Exhibit 9, # 10 Exhibit 10, # 11 Exhibit 11, # 12 Exhibit 12, # 13 Exhibit 13, # 14 Exhibit 14, # 15 Exhibit 15, # 16 Exhibit 16, # 17 Exhibit 17, # 18 Exhibit 18, # 19 Exhibit 19, # 20 Exhibit 20, # 21 Exhibit 21, # 22 Exhibit 22, # 23 Exhibit 23, # 24 Exhibit 24, # 25 Exhibit 25, # 26 Exhibit 26, # 27 Exhibit 27 (can't scan), # 28 Exhibit 28, # 29 Exhibit 29, # 30 Exhibit 30, # 31 Exhibit 31, # 32 Exhibit 32, # 33 Exhibit 33, # 34 Exhibit 34)(Moore, Kellyann) (Attachment 27 replaced on 2/12/2014) (Entered: 02/12/2014)
2372014-02-12 NOTICE of Appearance by Anna Rachel Dray-Siegel on behalf of Momenta Pharmaceuticals, Inc. (Dray-Siegel, Anna) (Entered: 02/12/2014)
2382014-02-12 Assented to MOTION for Extension of Time to 3/10/2014 to File Response/Reply as to 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 by Momenta Pharmaceuticals, Inc..(Dray-Siegel, Anna) (Entered: 02/12/2014)
2392014-02-13 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 238 Motion for Extension of Time to File Response/Reply re 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 Responses due by 3/10/2014 (Patch, Christine) (Entered: 02/13/2014)
2402014-03-10 Assented to MOTION to Seal Document Motion to Seal Plaintiffs' Opposition to Teva's Motion for Attorney Fees and Supporting Documents by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Murawski, Michael) (Entered: 03/10/2014)
2412014-03-11 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 240 Motion to Seal Document (Patch, Christine) (Entered: 03/11/2014)
2422014-03-11 SEALED Opposition re 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Moore, Kellyann) (Entered: 03/11/2014)
2432014-03-11 SEALED Declaration of Ishan Capila, Ph.D., In Support of 242 SEALED Opposition re 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 filed by Momenta Pharmaceuticals, Inc., Sandoz Inc. (Moore, Kellyann) (Entered: 03/11/2014)
2442014-03-11 SEALED Declaration of Robert S. Frank, Jr., In Support OF 242 SEALED Opposition re 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 filed by Momenta Pharmaceuticals, Inc., Sandoz Inc. (Moore, Kellyann) (Entered: 03/11/2014)
2452014-03-11 SEALED Declaration of Anna Rachel Dray-Siegel, Esq in support of 242 SEALED Opposition re 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 filed by Momenta Pharmaceuticals, Inc., Sandoz Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I, # 10 Exhibit J, # 11 Exhibit K, # 12 Exhibit L, # 13 Exhibit M, # 14 Exhibit N, # 15 Exhibit O, # 16 Exhibit P, # 17 Exhibit Q, # 18 Exhibit R, # 19 Exhibit S, # 20 Exhibit T, # 21 Exhibit U, # 22 Exhibit V, # 23 Exhibit W)(Moore, Kellyann) (Additional attachment(s) added on 3/11/2014: # 24 Exhibit X part 1, # 25 Exhibit X part 2) (Moore, Kellyann). (Entered: 03/11/2014)
2462014-03-27 Assented to MOTION to Seal Defendant Teva Pharmaceuticals USA, Inc.'s [Proposed] Reply In Support of Its Motion for Attorney Fees Under 35 U.S.C. § 285 by Teva Pharmaceuticals USA Inc.(Frederickson, Robert) (Entered: 03/27/2014)
2472014-03-28 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 246 Motion to Seal (Patch, Christine) (Entered: 03/28/2014)
2482014-03-31 Assented to MOTION for Leave to File Reply in support of its Motion for Attorney Fees Under 35 U.S.C. § 285 by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A Filed Under Seal)(Frederickson, Robert) (Entered: 03/31/2014)
2492014-03-31 NOTICE OF MANUAL FILING by Teva Pharmaceuticals USA Inc of its Proposed Reply in Support of Its Motion for Attorney Fees Under 35 U.S.C. § 285 (Frederickson, Robert) (Entered: 03/31/2014)
2502014-04-01 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 248 Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Patch, Christine) (Entered: 04/01/2014)
2512014-04-01 DECLARATION of Elaine Herrmann Blais in Support of Defendant Teva Pharmaceuticals USA, Inc.'s Reply In Support of Its Motion for Attorneys' Fees Under 35 U.S.C. § 285 by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit 35: Office Action dated May 18, 2006, # 2 Exhibit 36: Response to Restriction Requirement dated February 5, 2007)(Blais, Elaine) (Entered: 04/01/2014)
2522014-04-01 NOTICE OF MANUAL FILING by Teva Pharmaceuticals USA Inc of its Reply in Support of Its Motion for Attorney Fees Under 35 U.S.C. §285 (Blais, Elaine) (Entered: 04/01/2014)
2532014-03-31 SEALED Proposed Reply in Support of 233 Motion for Attorney Fees Under 35 U.S.C. § 285 by Teva Pharmaceuticals USA Inc. (Moore, Kellyann) (Entered: 04/02/2014)
2542014-04-01 SEALED REPLY to Response to 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 filed by Teva Pharmaceuticals USA, Inc. (Moore, Kellyann) (Entered: 04/02/2014)
2552014-05-01 MOTION for Leave to File (Defendant Teva Pharmaceuticals USA, Inc.'s Unopposed Motion for Leave to File a Notice of Supplemental Authority in Support of Its Motion for Attorney Fees Under 35 U.S.C. § 285) by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A - [Proposed] Notice of Supplemental Authority)(Blais, Elaine) (Entered: 05/01/2014)
2562014-05-02 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 255 Motion for Leave to File Document ; Counsel using the Electronic Case Filing System should now file the document for which leave to file has been granted in accordance with the CM/ECF Administrative Procedures. Counsel must include - Leave to file granted on (date of order)- in the caption of the document. (Patch, Christine) (Entered: 05/02/2014)
2572014-05-02 Notice of Supplemental Authorities re 233 MOTION for Attorney Fees Under 35 U.S.C. § 285 (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Blais, Elaine) (Entered: 05/02/2014)
2582014-06-30 Assented to MOTION to Withdraw Appearance of Michael E. Murawski by Momenta Pharmaceuticals, Inc., Sandoz Inc..(Wang, Sophie) (Entered: 06/30/2014)
2592014-07-01 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 258 Motion to Withdraw Appearance of Michael E. Murawski. (Patch, Christine) (Entered: 07/01/2014)
2602014-11-20 Judge Nathaniel M. Gorton: ORDER entered. MEMORANDUM AND ORDER: "For the foregoing reasons, Teva's motion for attorneys' fees (Docket No. 233 ) is DENIED.So ordered."(Moore, Kellyann) (Entered: 11/20/2014)
2612015-11-10 OPINION and JUDGMENT of USCA for the Federal Circuit as to 223 Notice of Appeal to the Federal Circuit, filed by Momenta Pharmaceuticals, Inc., Sandoz Inc., 227 Notice of Appeal to the Federal Circuit, filed by Momenta Pharmaceuticals, Inc., Sandoz Inc..The judgment or decision is: the decision of the district court granting summary judgment to Teva is AFFIRMED and the decision of the district court granting summary judgment to Amphastar is AFFIRMED-IN-PART, VACATED-IN-PART, AND REMANDED. (Attachments: # 1 USCA Federal Circuit Notice)(Paine, Matthew) (Entered: 11/10/2015)
2622015-11-13 Set Deadlines: Status Report in re 261 OPINION and JUDGMENT of USCA for the Federal Circuit due by 11/24/2015 (Danieli, Chris) (Entered: 11/13/2015)
2632015-11-24 STATUS REPORT Interim Joint by Momenta Pharmaceuticals, Inc., Sandoz Inc.. (Wang, Sophie) (Entered: 11/24/2015)
2642016-01-19 MANDATE of USCA as to 223 Notice of Appeal to the Federal Circuit, filed by Momenta Pharmaceuticals, Inc., Sandoz Inc., 227 Notice of Appeal to the Federal Circuit, filed by Momenta Pharmaceuticals, Inc., Sandoz Inc.. Appeal 223 , 227 Terminated (Paine, Matthew) (Entered: 01/19/2016)
2652016-01-27 Set/Reset Deadlines: Status Report due by 2/3/2016 (Lima, Christine) (Entered: 01/27/2016)
2662016-02-03 STATUS REPORT (Interim Joint Status Report) by Teva Pharmaceuticals USA Inc. (Blais, Elaine) (Entered: 02/03/2016)
2672016-02-03 Assented to MOTION for Extension of Time to February 17, 2016 to Seek Costs Under Fed. R. Civ. P. 54(d)(1) and 28 U.S.C. s. 1920 by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Text of Proposed Order)(Blais, Elaine) (Entered: 02/03/2016)
2682016-02-09 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 267 Motion for Extension of Time to 2/17/16 to Seek Costs. (Lima, Christine) (Entered: 02/09/2016)
2692016-02-16 Assented to MOTION for Extension of Time to February 24, 2016 to Seek Costs Under Fed. R. CIV. P. 54(d)(1) and 28 U.S.C. s. 1920 by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Text of Proposed Order)(Blais, Elaine) (Entered: 02/16/2016)
2702016-02-17 Judge Nathaniel M. Gorton: ELECTRONIC ORDER entered granting 269 Motion for Extension of Time for Seeking Costs. (Lima, Christine) (Entered: 02/17/2016)
2712016-02-24 NOTICE of Withdrawal of Appearance by Sophie F. Wang of Anna Rachel Dray-Siegel (Wang, Sophie) (Entered: 02/24/2016)
2722016-02-24 Assented to MOTION for Bill of Costs (Assented-to Motion to Recover Costs as the Prevailing Party) by Teva Pharmaceuticals USA Inc.(Blais, Elaine) (Entered: 02/24/2016)
2732016-02-24 EXHIBIT re 272 Assented to MOTION for Bill of Costs (Assented-to Motion to Recover Costs as the Prevailing Party) [Proposed] Order by Teva Pharmaceuticals USA Inc. (Blais, Elaine) (Entered: 02/24/2016)
2742016-02-24 MEMORANDUM in Support re 272 Assented to MOTION for Bill of Costs (Assented-to Motion to Recover Costs as the Prevailing Party) filed by Teva Pharmaceuticals USA Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F)(Blais, Elaine) (Entered: 02/24/2016)
2752016-02-25 ELECTRONIC NOTICE issued requesting courtesy copy for 274 Memorandum in Support of Motion. Counsel who filed this document are requested to submit a courtesy copy of it to the Clerk's Office. These documents must be clearly marked as a Courtesy Copy and reflect the document number assigned by CM/ECF. (Lima, Christine) (Entered: 02/25/2016)
2762016-03-01 Judge Nathaniel M. Gorton: ENDORSED ORDER entered granting 272 Motion for Bill of Costs (Caruso, Stephanie) (Main Document 276 replaced on 3/2/2016) (Caruso, Stephanie). (Entered: 03/02/2016)
2772016-03-01 Judge Nathaniel M. Gorton: ENDORSED ORDER entered. re 276 Order on Motion for Bill of Costs (Caruso, Stephanie) (Entered: 03/02/2016)